Suchergebnisse - "Xia, Zhongjun"

PubPharm (6)

1

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China : a retrospective multicenter study

enthalten in: Cancer biology & medicine | 2023

von Fan, H. | Wang, W. | Zhang, Y. | +6

2

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma : A multicenter study

enthalten in: Cancer medicine | 2022

von Zhang, Y. | Liu, P. | Cai, J. | +19

3

Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma : A multicenter study

enthalten in: American journal of hematology | 2021

von Zhang, Y. | Ma, S. | Cai, J. | +17

4

A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: British journal of cancer | 2021

von Cai, J. | Tian, X. | Ma, S. | +15

5

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial : a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

6

A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience

enthalten in: Cancer research and treatment | 2020

von Li, C. | Wuxiao, Z. | Chen, X. | +5

1
[1]